Android app on Google Play

Standpoint Research Upgrades Hi Tech Pharmacal (HITK) to Buy

March 14, 2013 10:51 AM EDT Send to a Friend
Get Alerts HITK Hot Sheet
Price: $43.49 --0%

Rating Summary:
    1 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 7
Trade HITK Now!
Join SI Premium – FREE
Standpoint Research upgraded Hi Tech Pharmacal (NASDAQ: HITK) from Hold to Buy with a price target of $42.00.

For an analyst ratings summary and ratings history on Hi Tech Pharmacal click here. For more ratings news on Hi Tech Pharmacal click here.

Shares of Hi Tech Pharmacal closed at $34.10 yesterday.




You May Also Be Interested In


Related Categories

Upgrades

Related Entities

Standpoint Research

Add Your Comment